drugset / Trial / NCT03006380

Prophylactic Oxytocin Before Versus After Placental Delivery to Reduce Blood Loss in Vaginal Delivery

NCT03006380 ↗

Phase 2 Unknown 400 enrolled Ain Shams Maternity Hospital
RandomizedParallel-groupDouble-blindPrevention

Summary

Randomized controlled study to assess the efficacy and safety of the timing of administration of prophylactic oxytocin via intramuscular route (before compared to after placental delivery) on blood loss in vaginal delivery.

Timeline

Start
2016-08
Primary completion
2017-08
Completion
2017-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxytocin Peptide 10 iu Intramuscular

Indications

No indication recorded.